z-logo
open-access-imgOpen Access
Comparison of the Inhibitory Effects of Antithrombin III, α2-Macroglobulin, and Thrombin in Human Basilar Arteries: Relevance to Cerebral Vasospasm
Author(s) -
Richard P. White
Publication year - 1987
Publication title -
journal of cerebral blood flow and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.167
H-Index - 193
eISSN - 1559-7016
pISSN - 0271-678X
DOI - 10.1038/jcbfm.1987.10
Subject(s) - basilar artery , tachyphylaxis , cerebral arteries , medicine , endocrinology , thrombin , cerebral vasospasm , prostacyclin , vasospasm , anesthesia , chemistry , subarachnoid hemorrhage , platelet
Isolated human basilar arteries were used in this study to evaluate the inhibitory effect of antithrombin III (AT III), thrombin, and α 2 -macroglobulin (α 2 -M) on contractions elicited by K + , serotonin (5-HT), prostaglandin (PG) D 2 , PGF 2α , and plasmin. α 2 -M (0.5–1.0 mg/ml) failed to affect the contractions produced by contractile agonists significantly but did notably reduce the basal tone of the arteries. Thrombin (1 and 10 U/ml) reduced basal tone and significantly inhibited the contractions elicited by K + , PGF 2α , and plasmin. The relaxant effect of thrombin was abolished by procedures that destroy endothelium and by exposing the artery to thrombin for prolonged periods (tachyphylaxis). AT III (1–6 U/ml) reduced basal tone and significantly inhibited, in a concentration-dependent manner, the contractile responses to K + , 5-HT, PGD 2 , PGF 2α , and plasmin. In sharp contrast to thrombin, AT III did not induce tachyphylaxis nor was its vasorelaxant effect significantly reduced by destruction of the endothelium. The results show AT III to be a potent and nonspecific inhibitor of human cerebral arteries and support the hypothesis that AT III may contribute to the delay of cerebral vasospasm seen in patients who experience aneurysmal hemorrhage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom